By Inside Your Peptides · Methods explainer · BIPM report published May 2020 · Source checked 2026-09-17
Two percentages can look like a simple contest: the higher result wins. That comparison becomes much less simple when the laboratories measured different quantities, used different methods, or worked from different samples. Before deciding that one report proves the other wrong, check what the numbers mean.
This is a methods explainer, not breaking news. Its central source is a BIPM report published in May 2020, checked here on 17 September 2026. The age is part of the citation, not something hidden behind a fresh article date.
A real comparison, not a supplier claim
The CCQM-K115.b synthetic-oxytocin comparison examined peptide mass-fraction assignment across metrology laboratories. Its analysis emphasizes the effect of correctly identifying and quantifying related peptide impurities. Methods included mass-balance and impurity-corrected approaches. The report discusses results with their uncertainties rather than treating each reported value as an exact, context-free truth.
Earlier NIST research published on 27 March 2018 investigated several approaches to assigning peptide purity using angiotensin I. It compared methods including mass balance, impurity-corrected amino-acid analysis, elemental analysis, and quantitative nuclear magnetic resonance. That work concerns analytical value assignment, not authorization for human use.
Uncertainty is information, not an escape hatch
NIST’s measurement-uncertainty guidance explains uncertainty as information about the dispersion of values reasonably attributable to the measured quantity. The page was updated on 17 March 2025. An uncertainty statement helps interpretation; it is not permission to dismiss any disagreement without investigating it.
Our reader workflow starts earlier than the percentage. Put the two complete reports side by side and write the quantity each one claims to measure. Keep the units and reporting basis attached. A chromatographic peak-area percentage and a mass fraction should not be silently relabeled as the same result. If the basis is missing, ask the laboratory rather than inventing a conversion.
The comparison sheet that prevents bad conclusions
First, match the material. Record the stated compound, form, exact lot, sample identifier, accession, client or submitter, sample source, and dates. “Same compound” is not evidence of “same sample.” If samples came from different containers or were submitted at different times, retain that distinction in your notes.
Second, match the measurement. Copy the test name, method identifier, units, and result exactly. Ask what the measurement includes and excludes. Record whether the document reports identity, relative chromatographic purity, or quantified content. Do not let one test answer a question it was not designed to answer.
Third, preserve the context. Request the laboratory’s explanation of calibration, relevant uncertainty, and any report limitations. Record handling or storage information supplied with the samples without inventing it. If uncertainty is absent from a report, mark it absent; do not add your own interval.
Finally, send a focused question to the issuing laboratory: “Are these results comparable on the stated basis, and what additional information is needed?” A specific request is more useful than asking which percentage is “right.” An unresolved mismatch should stay unresolved until the evidence supports a narrower conclusion.
FAQ
Does a higher purity percentage mean more peptide per container?
Not from that percentage alone. Identify the reported quantity and look for a separate quantified-content result where that is the question you need answered.
Does disagreement prove fraud?
No. It warrants investigation. Different samples, reporting bases, methods, or an error may matter; the documents must establish which explanation applies.
Does agreement establish sterility or clinical suitability?
No. Agreement on one chemical measurement cannot answer unrelated microbiological or human-use questions.
The takeaway: compare like with like before comparing high with low. For a wider document checklist, read the testing explainer. It is a reading tool, not a guarantee about any supplier’s material.
Sources and scope
Source links checked 2026-09-17. A source check is not confirmation of every underlying claim.